Target intelligence / Profile preview

OSTN antisense RNA 1 (OSTN-AS1)

Target
OSTN-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other
01

Overview

OSTN antisense RNA 1 (OSTN-AS1) is a human long non-coding RNA (lncRNA) transcribed from the antisense strand of the OSTN gene. It does not encode a protein but regulates gene expression, primarily through its function as a ceRNA (competing endogenous RNA). OSTN-AS1 has been identified as strongly associated with immune regulation, as its expression correlates with key immune genes involved in T-cell and B-cell receptor signaling, immune checkpoint molecules (e.g., PDCD1, CTLA-4), and immune cell infiltration, particularly in the context of cancer. Expression of OSTN-AS1 is reported to be lower in most tumor samples relative to normal tissue and may act as a prognostic biomarker for immune function and disease outcome, particularly in triple-negative breast cancer. Its potential utility lies in prognosis and immunological profiling rather than as a direct therapeutic target[4][5][7].

Other names
OSTN-AS1OSTN antisense RNA 1 (non-protein coding)
02

Biological functions

Regulation of gene expression (acts as a competing endogenous RNA/ceRNA)Association with immune regulationCorrelated with immune cell infiltration (T cells, B cells, NK cells)Linked with immune signaling pathways (T- and B-cell receptor signaling)
03

Disease associations

Potential prognostic marker in cancer (notably triple-negative breast cancer)Immune system modulationOther
04

Biomarkers

Low OSTN-AS1 expression is associated with certain tumor types (such as TNBC) and serves as a prognostic immune-related marker

Beyond the preview

Go deeper on OSTN antisense RNA 1 (OSTN-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OSTN antisense RNA 1 (OSTN-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call